2026. Nemolizumab Long-Term Safety and Efficacy up to 148 Weeks in the OLYMPIA Open-Label Extension Study in Patients with Prurigo Nodularis. SKIN The Journal of Cutaneous Medicine. 10, 3 (May 2026), s779. DOI:https://doi.org/10.25251/3gr50m60.